Invalidation arguments on remand failed, unsealed ruling shows Schizophrenia drug had nearly $3 billion in US sales in 2023 Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit convinced a federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback